Export translations

Settings

Group

Language

Format

Export for off-line translation

Export in native format

Export in CSV format

{{DISPLAYTITLE:低血糖症}}<languages />
{{Infobox medical condition (new)
| name          = 低血糖症
| synonyms      = Hypoglycaemia, hypoglycæmia, low blood glucose, low blood sugar
| image         = Glucose test.JPG
| caption       = [[Glucose meter/ja]]
| field         = [[Endocrinology/ja]]
| symptoms      = 頭痛、目のかすみ、ふるえ、めまい、脱力感、疲労感、発汗、しめつけ感、速い心拍数、ドキドキする心拍、神経質または不安、空腹感、吐き気、針が刺すような感覚、会話困難、錯乱、[[loss of consciousness/ja|意識消失]]、異常行動、ふらつき、皮膚の色が青白い、[[seizures/ja|発作]]、死亡
| complications =
| onset         = Rapid
| duration      =
| causes        = [[Anti-diabetic medication/ja|医薬品]] ([[insulin/ja]], [[glinide/ja]]と[[sulfonylurea/ja]]), [[sepsis/ja]], [[kidney failure/ja]], 特定の[[tumor/ja]], [[liver disease/ja]]
| risks         =
| diagnosis     = ウィップルの三徴候： 低血糖症状、血清血糖値＜70mg/dL（3.9mmol/L）、血糖値が正常に戻ると症状が消失する。
| differential  =
| prevention    =
| treatment     = 単糖類、[[dextrose/ja|ブドウ糖]]、[[Glucagon (medication)/ja|グルカゴン]]を多く含む食品を食べる。
| medication    =
| prognosis     =
| frequency     = 1型糖尿病患者では、軽度の低血糖は平均して週に2回起こり、重度の低血糖は年に1回起こる。
| deaths        = 1型糖尿病患者では、6-10％が低血糖で死亡する。
}}

'''低血糖'''とも呼ばれる'''低血糖症'''とは、[[blood sugar/ja|血糖値]]が正常値以下、典型的には70&nbsp;mg/dL（3.9&nbsp;mmol/L）以下に低下することである。[[Whipple's triad/ja|ウィップルの三徴]]は、低血糖エピソードを適切に識別するために用いられる。これは、70&nbsp;mg/dL（3.9&nbsp;mmol/L）未満の血糖、低血糖に伴う症状、および血糖が正常に戻ったときの症状の消失と定義される。低血糖症は、頭痛、疲労感、不器用さ、会話障害、[[confusion/ja|錯乱]]、速い心拍数、発汗、震え、神経過敏、空腹感、[[loss of consciousness/ja|意識消失]]、[[seizures/ja|痙攣]]、または死に至ることがある。

<div lang="en" dir="ltr" class="mw-content-ltr">

The most common cause of hypoglycemia is [[Anti-diabetic medication|medications]] used to treat diabetes such as [[Insulin (medication)|insulin]], [[sulfonylurea]]s, and [[biguanide]]s. Risk is greater in diabetics who have eaten less than usual, recently exercised, or consumed [[ethanol|alcohol]]. Other causes of hypoglycemia include severe illness, [[sepsis]], [[kidney failure]], [[liver disease]], [[hormone]] deficiency, [[tumor]]s such as [[insulinoma]]s or non-B cell tumors, [[inborn error of metabolism|inborn errors of metabolism]], several medications, and alcohol. Low blood sugar may occur in otherwise healthy newborns who have not eaten for a few hours.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">

Hypoglycemia is treated by eating a sugary food or drink, for example glucose tablets or gel, apple juice, soft drink, or lollies. The person must be [[Consciousness|conscious]] and able to swallow. The goal is to consume 10–20 grams of a carbohydrate to raise blood glucose levels to a minimum of 70&nbsp;mg/dL (3.9&nbsp;mmol/L). If a person is not able to take food by mouth, [[Glucagon (medication)|glucagon]] by injection or insufflation may help. The treatment of hypoglycemia unrelated to diabetes includes treating the underlying problem.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
Among people with diabetes, prevention starts with learning the signs and symptoms of hypoglycemia. Diabetes medications, like [[Insulin (medication)|insulin]], [[sulfonylurea]]s, and [[biguanide]]s can also be adjusted or stopped to prevent hypoglycemia. Frequent and routine blood glucose testing is recommended. Some may find continuous glucose monitors with insulin pumps to be helpful in the management of diabetes and prevention of hypoglycemia.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
== Definition ==
Blood sugar levels naturally fluctuate throughout the day, however ''hypoglycemia'', also called ''low blood sugar'' or ''low blood glucose,'' is when blood sugar levels drop below 70&nbsp;mg/dL (3.9&nbsp;mmol/L).
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
Blood sugar levels are generally maintained between 70 and 110&nbsp;mg/dL (3.9–6.1&nbsp;mmol/L). Although 70&nbsp;mg/dL (3.9&nbsp;mmol/L) is the lower limit of normal glucose, symptoms of hypoglycemia usually do not occur until 55&nbsp;mg/dL (3.0&nbsp;mmol/L) or lower. The blood glucose level at which symptoms of hypoglycemia develop in someone with several prior episodes of hypoglycemia may be even lower.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
=== Whipple's triad ===
The symptoms of low blood sugar alone are not specific enough to characterize a hypoglycemic episode. A single blood sugar reading below 70&nbsp;mg/dL is also not specific enough characterize a hypoglycemic episode. ''[[Whipple's triad]]'' is a set of three conditions that need to be met to accurately characterize a hypoglycemic episode.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
The three conditions are the following:
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
# The signs and symptoms of hypoglycemia are present (see section below on ''Signs and Symptoms'')
# A low blood glucose measurement is present, typically less than 70&nbsp;mg/dL (3.9&nbsp;mmol/L)
# The signs and symptoms of hypoglycemia resolve after blood glucose levels have returned to normal
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
===Age===
The biggest difference in blood glucose levels between the adult and pediatric population occurs in newborns during the first 48 hours of life. After the first 48 hours of life, the Pediatric Endocrine Society cites that there is little difference in blood glucose level and the use of glucose between adults and children. During the 48-hour neonatal period, the neonate adjusts [[glucagon]] and [[Adrenaline|epinephrine]] levels following birth, which may cause temporary hypoglycemia. As a result, there has been difficulty in developing guidelines on interpretation and treatment of low blood glucose in neonates aged less than 48 hours. Following a data review, the Pediatric Endocrine Society concluded that neonates aged less than 48 hours begin to respond to hypoglycemia at serum glucose levels of 55–65&nbsp;mg/dL (3.0–3.6&nbsp;mmol/L). This is contrasted by the value in adults, children, and older infants, which is approximately 80–85&nbsp;mg/dL (4.4–4.7&nbsp;mmol/L).
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
In children who are aged greater than 48 hours, serum glucose on average ranges from 70 to 100&nbsp;mg/dL (3.9–5.5&nbsp;mmol/L), similar to adults. Whipple's triad is used to identify hypoglycemia in children who can communicate their symptoms.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
== Differential diagnosis ==
Other conditions that may present at the same time as hypoglycemia include the following:
* Alcohol or [[Substance intoxication|drug intoxication]]
* [[Arrhythmia|Cardiac arrhythmia]]
* [[Valvular heart disease]]
* Postprandial syndrome
* [[Hyperthyroidism]]
* [[Pheochromocytoma]]
* Post-gastric bypass hypoglycemia
* [[Generalized anxiety disorder]]
* Surreptitious insulin use
* Lab or blood draw error (lack of antiglycolytic agent in collection tube or during processing)
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
==Signs and symptoms==
Hypoglycemic symptoms are divided into two main categories. The first category is symptoms caused by low glucose in the brain, called [[Neuroglycopenia|neuroglycopenic]] symptoms. The second category of symptoms is caused by the body's reaction to low glucose in the brain, called [[adrenergic]] symptoms.
{| class="wikitable"
!Neuroglycopenic symptoms
!Adrenergic symptoms
|-
|
* [[Headache]]
* [[Blurred vision]]
* Tiredness (also called ''[[fatigue]]'')
* Unusual behavior
* [[Confusion]]
* [[Lightheadedness]]
* Difficulty speaking or slurred speech
* [[Seizure]]s
* [[Unconsciousness|Loss of consciousness]] (sometimes called ''passing out'')
* Death, if severe hypoglycemia
|
* [[Tachycardia|Fast heart rate]]
* Pounding heartbeat (also called ''[[palpitations]]'')
* [[Perspiration|Sweating]]
* Clamminess
* [[Tremor]]s
* Nervousness (also called ''[[anxiety]]'')
* Hunger
* [[Irritability]] (also called being ''[[wikt:hangry|hangry]]'')
* [[Nausea]]
* [[Paresthesia|Pins and needles sensation]]
* Pale skin color
|-
| colspan="2" |References:
|}
Everyone experiences different symptoms of hypoglycemia, so someone with hypoglycemia may not have all of the symptoms listed above. Symptoms also tend to have quick onset. It is important to quickly obtain a blood glucose measurement in someone presenting with symptoms of hypoglycemia to properly identify the hypoglycemic episode.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
==Pathophysiology==
[[Glucose]] is the main source of energy for the brain, and a number of mechanisms are in place to prevent hypoglycemia and protect energy supply to the brain. The body can adjust [[insulin]] production and release, adjust glucose production by the [[liver]], and adjust glucose use by the body. The body naturally produces the hormone [[insulin]], in an organ called the [[pancreas]]. Insulin helps to regulate the amount of glucose in the body, especially after meals. [[Glucagon]] is another hormone involved in regulating blood glucose levels, and can be thought of as the opposite of insulin. Glucagon helps to increase blood glucose levels, especially in states of hunger.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
When blood sugar levels fall to the low-normal range, the first line of defense against hypoglycemia is decreasing [[insulin]] release by the [[pancreas]]. This drop in insulin allows the [[liver]] to increase [[glycogenolysis]]. [[Glycogenolysis]] is the process of [[glycogen]] breakdown that results in the production of glucose. [[Glycogen]] can be thought of as the inactive, storage form of glucose. Decreased insulin also allows for increased [[gluconeogenesis]] in the [[liver]] and [[kidney]]s. [[Gluconeogenesis]] is the process of glucose production from non-[[carbohydrate]] sources, supplied from muscles and fat.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
Once blood glucose levels fall out of the normal range, additional protective mechanisms work to prevent hypoglycemia. The [[pancreas]] is signaled to release [[glucagon]], a [[hormone]] that increases glucose production by the liver and kidneys, and increases muscle and fat breakdown to supply [[gluconeogenesis]]. If increased glucagon does not raise blood sugar levels to normal, the adrenal glands release [[Adrenaline|epinephrine]]. [[Adrenaline|Epinephrine]] works to also increase [[gluconeogenesis]] and [[glycogenolysis]], while also decreasing the use of glucose by organs, protecting the brain's glucose supply.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
After hypoglycemia has been prolonged, [[cortisol]] and [[growth hormone]] are released to continue [[gluconeogenesis]] and [[glycogenolysis]], while also preventing the use of glucose by other organs. The effects of cortisol and growth hormone are far less effective than epinephrine. In a state of hypoglycemia, the brain also signals a sense of hunger and drives the person to eat, in an attempt to increase glucose.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
==Causes==
{{main|List of causes of hypoglycemia}}Hypoglycemia is most common in those with diabetes treated by [[Insulin (medication)|insulin]], [[glinides]], and [[sulfonylurea]]s. Hypoglycemia is rare in those without diabetes, because there are many regulatory mechanisms in place to appropriately balance [[glucose]], [[Insulin (medication)|insulin]], and [[glucagon]]. Please refer to ''Pathophysiology'' section (above) for more information on [[glucose]], [[Insulin (medication)|insulin]], and [[glucagon]].
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
=== Diabetics ===
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
==== Medications ====
The most common cause of hypoglycemia in diabetics is medications used to treat diabetes such as [[Insulin (medication)|insulin]], [[sulfonylurea]]s, and [[biguanide]]s. This is often due to excessive doses or poorly timed doses. Sometimes diabetics may take insulin in anticipation of a meal or snack; then forgetting or missing eating that meal or snack can lead to hypoglycemia. This is due to increased insulin without the presence of glucose from the planned meal.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
==== Hypoglycemic unawareness ====
Recurrent episodes of hypoglycemia can lead to ''hypoglycemic unawareness'', or the decreased ability to recognize hypoglycemia. As diabetics experience more episodes of hypoglycemia, the blood glucose level which triggers symptoms of hypoglycemia decreases. In other words, people ''without'' hypoglycemic unawareness experience symptoms of hypoglycemia at a blood glucose of about 55&nbsp;mg/dL (3.0&nbsp;mmol/L). Those ''with'' hypoglycemic unawareness experience the symptoms of hypoglycemia at far lower levels of blood glucose. This is dangerous for a number of reasons. The hypoglycemic person not only gains awareness of hypoglycemia at very low blood glucose levels, but they also require high levels of carbohydrates or glucagon to recover their blood glucose to normal levels. These individuals are also at far greater risk of severe hypoglycemia.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
While the exact cause of hypoglycemic unawareness is still under research, it is thought that these individuals progressively begin to develop fewer adrenergic-type symptoms, resulting in the loss of neuroglycopenic-type symptoms. ''Neuroglycopenic symptoms'' are caused by low glucose in the brain, and can result in tiredness, confusion, difficulty with speech, seizures, and loss of consciousness. ''Adrenergic symptoms'' are caused by the body's reaction to low glucose in the brain, and can result in fast heart rate, sweating, nervousness, and hunger. See section above on ''Signs and Symptoms'' for further explanation of neuroglycopenic symptoms and adrenergic symptoms.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
In terms of epidemiology, hypoglycemic unawareness occurs in 20–40% of type 1 diabetics.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
==== Other causes ====
Other causes of hypoglycemia in diabetics include the following:
* Fasting, whether it be a planned [[Fasting|fast]] or overnight [[Fasting|fast]], as there is a long period of time without glucose intake
* Exercising more than usual as it leads to more use of glucose, especially by the muscles
* Drinking alcohol, especially when combined with diabetic medications, as alcohol inhibits glucose production
* [[Kidney disease]], as insulin cannot be cleared out of circulation well
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
=== Non-diabetics ===
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
==== Serious illness ====
Serious illness may result in low blood sugar. Severe disease of many organ systems can cause hypoglycemia as a secondary problem. Hypoglycemia is especially common in those in the [[intensive care unit]] or those in whom food and drink is withheld as a part of their treatment plan.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
[[Sepsis]], a common cause of hypoglycemia in serious illness, can lead to hypoglycemia through many ways. In a state of sepsis, the body uses large amounts of glucose for energy. Glucose use is further increased by [[cytokine]] production. [[Cytokine]]s are a protein produced by the body in a state of stress, particularly when fighting an infection. [[Cytokine]]s may inhibit glucose production, further decreasing the body's energy stores. Finally, the [[liver]] and [[kidney]]s are sites of glucose production, and in a state of sepsis those organs may not receive enough oxygen, leading to decreased glucose production due to organ damage.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
Other causes of serious illness that may cause hypoglycemia include liver failure and kidney failure. The [[liver]] is the main site of glucose production in the body, and any liver failure or damage will lead to decreased glucose production. While the [[kidney]]s are also sites of glucose production, their failure of glucose production is not significant enough to cause hypoglycemia. Instead, the kidneys are responsible for removing insulin from the body, and when this function is impaired in kidney failure, the insulin stays in circulation longer, leading to hypoglycemia.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
==== Drugs ====
A number of medications have been identified which may cause hypoglycemia, through a variety of ways. Moderate quality evidence implicates the [[Nonsteroidal anti-inflammatory drug|non-steroidal anti-inflammatory]] drug [[Indometacin|indomethacin]] and the anti-malarial [[quinine]]. Low quality evidence implicates [[Lithium (medication)|lithium]], used for [[bipolar disorder]]. Finally, very low quality evidence implicates a number of [[hypertension]] medications including [[angiotensin converting enzyme inhibitors]] (also called ACE-inhibitors), [[Angiotensin II receptor blocker|angiotensin receptor blockers]] (also called ARBs), and [[Beta blocker|β-adrenergic blockers]] (also called beta blockers). Other medications with very low quality evidence include the antibiotics [[levofloxacin]] and [[Trimethoprim/sulfamethoxazole|trimethoprim-sulfamethoxazole]], progesterone blocker [[mifepristone]], anti-arrhythmic [[disopyramide]], anti-coagulant [[heparin]], and chemotherapeutic [[mercaptopurine]].
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
If a person without diabetes accidentally takes medications that are traditionally used to treat diabetes, this may also cause hypoglycemia. These medications include [[Insulin (medication)|insulin]], [[Meglitinide|glinides]], and [[sulfonylurea]]s. This may occur through medical errors in a healthcare setting or through pharmacy errors, also called [[Iatrogenesis|iatrogenic]] hypoglycemia.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
==== Surreptitious insulin use ====
When individuals take insulin without needing it, to purposefully induce hypoglycemia, this is referred to as ''surreptitious insulin use'' or ''factitious hypoglycemia''. Some people may use insulin to induce weight loss, whereas for others this may be due to [[malingering]] or [[factitious disorder]], which is a psychiatric disorder. Demographics affected by factitious hypoglycemia include women aged 30–40, particularly those with diabetes, relatives with diabetes, healthcare workers, or those with history of a psychiatric disorder. The classic way to identify surreptitious insulin use is through blood work revealing high insulin levels with low [[C-peptide]] and [[proinsulin]].
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
==== Alcohol misuse ====
The production of glucose is blocked by alcohol. In those who misuse alcohol, hypoglycemia may be brought on by a several-day alcohol binge associated with little to no food intake. The cause of hypoglycemia is multifactorial, where [[glycogen]] becomes depleted in a state of [[starvation]]. Glycogen stores are then unable to be repleted due to the lack of food intake, all compounded the inhibition of glucose production by alcohol.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
====Hormone deficiency====
Children with primary adrenal failure, also called [[Addison's disease]], may experience hypoglycemia after long periods of [[fasting]]. [[Addison's disease]] is associated with chronically low levels of the stress hormone [[cortisol]], which leads to decreased glucose production.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
[[Hypopituitarism]], leading to decreased [[growth hormone]], is another cause of hypoglycemia in children, particularly with long periods of fasting or increased exercise.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
==== Inborn errors of metabolism ====
Briefly, [[inborn errors of metabolism]] are a group of rare [[genetic disorder]]s that are associated with the improper breakdown or storage of [[protein]]s, [[carbohydrate]]s, or [[fatty acid]]s. Inborn errors of metabolism may cause infant hypoglycemia, and much less commonly adult hypoglycemia.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
Disorders that are related to the breakdown of glycogen, called [[Glycogen storage disease|''glycogen storage diseases'']], may cause hypoglycemia. Normally, breakdown of glycogen leads to increased glucose levels, particularly in a fasting state. In [[glycogen storage disease]]s however, glycogen cannot be properly broken-down, leading to inappropriately decreased glucose levels in a fasting state, and thus hypoglycemia. The glycogen storage diseases associated with hypoglycemia include [[Glycogen storage disease type 0|type 0]], [[Glycogen storage disease type I|type I]], [[Glycogen storage disease type III|type III]], and [[Glycogen storage disease type IV|type IV]], as well as [[Fanconi syndrome]].
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
Some [[Organic acidemia|organic]] and amino acid acidemias, especially those involving the oxidation of fatty acids, can lead to the symptom of intermittent hypoglycemia, as for example in [[combined malonic and methylmalonic aciduria]] (CMAMMA), [[propionic acidemia]] or isolated [[methylmalonic acidemia]].
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
==== Insulinomas ====
A primary B-cell [[Neoplasm|tumor]], such as an [[insulinoma]], is associated with hypoglycemia. This is a tumor located in the [[pancreas]]. An insulinoma produces [[insulin]], which in turn decreases glucose levels, causing hypoglycemia. Normal regulatory mechanisms are not in place, which prevent insulin levels from falling during states of low blood glucose. During an episode of hypoglycemia, plasma [[insulin]], [[C-peptide]], and [[proinsulin]] will be inappropriately high.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
==== Non-B cell tumors ====
Hypoglycemia may occur in people with non-B cell [[Neoplasm|tumors]] such as [[hepatoma]]s, adrenocorticoid carcinomas, and [[carcinoid]] tumors. These tumors lead to a state of increased insulin, specifically increased [[Insulin-like growth factor 2|insulin-like growth factor II]], which decreases glucose levels.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
==== Post-gastric bypass postprandial hypoglycemia ====
The [[Gastric bypass surgery|Roux-en-Y gastric bypass]], is a weight-loss surgery performed on the stomach, and has been associated with hypoglycemia, called ''post-gastric bypass [[postprandial hypoglycemia]]''. Although the entire mechanism of hypoglycemia following this surgery is not fully understood, it is thought that meals cause very high levels of [[glucagon-like peptide-1]] (also called GLP-1), a hormone that increases insulin, causing glucose levels to drop.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
==== Autoimmune hypoglycemia ====
[[Antibody|Antibodies]] can be formed against insulin, leading to [[Autoimmunity|autoimmune]] hypoglycemia. [[Antibody|Antibodies]] are immune cells produced by the body, that normally attack bacteria and viruses, but sometimes can attack normal human cells, leading to an [[Autoimmune disease|autoimmune disorder]]. In autoimmune hypoglycemia, there are two possible mechanisms. In one instance, antibodies bind to insulin following its release associated with a meal, resulting in insulin being non-functional. At a later time, the antibodies fall off insulin, causing insulin to be functional again leading late hypoglycemia after a meal, called ''late postprandial hypoglycemia''. Another mechanism causing hypoglycemia is due to antibodies formed against insulin [[Receptor (biochemistry)|receptors]], called ''insulin receptor antibodies''. The antibodies attach to insulin receptors and prevent insulin breakdown, or degradation, leading to inappropriately high insulin levels and low glucose levels.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
==== Neonatal hypoglycemia ====
Low blood sugar may occur in healthy [[Infant|neonates]] aged less than 48 hours who have not eaten for a few hours. During the 48-hour neonatal period, the neonate adjusts [[glucagon]] and [[Adrenaline|epinephrine]] levels following birth, which may trigger transient hypoglycemia. In children who are aged greater than 48 hours, serum glucose on average ranges from 70 to 100&nbsp;mg/dL (3.9–5.5&nbsp;mmol/L), similar to adults, with hypoglycemia being far less common.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
==Diagnostic approach==
The most reliable method of identifying hypoglycemia is through identifying [[Whipple's triad]]. The components of [[Whipple's triad]] are a blood sugar level below 70&nbsp;mg/dL (3.9&nbsp;mmol/L), symptoms related to low blood sugar, and improvement of symptoms when blood sugar is restored to normal. Identifying [[Whipple's triad]] in a patient helps to avoid unnecessary [[Medical test|diagnostic testing]] and decreases [[Health care prices in the United States|healthcare costs]].
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
In those with a history of diabetes treated with [[Insulin (medication)|insulin]], [[Meglitinide|glinides]], or [[sulfonylurea]], who demonstrate Whipple's triad, it is reasonable to assume the cause of hypoglycemia is due to insulin, glinides, or sulfonylurea use. In those without a history of diabetes with hypoglycemia, further diagnostic testing is necessary to identify the cause. Testing, during an episode of hypoglycemia, should include the following:
* [[Blood sugar level|Plasma glucose]] level, not [[Point of care|point-of-care]] measurement
* Insulin level
* [[C-peptide]] level
* [[Proinsulin]] level
* [[Beta-Hydroxybutyric acid|Beta-hydroxybutyrate]] level
* Oral hypoglycemic agent screen
* Response of blood glucose level to glucagon
* Insulin [[Antibody|antibodies]]
If necessary, a diagnostic hypoglycemic episode can be produced in an inpatient or outpatient setting. This is called a diagnostic [[Fasting|fast]], in which a patient undergoes an observed fast to cause a hypoglyemic episode, allowing for appropriate blood work to be drawn. In some, the hypoglycemic episode may be reproduced simply after a mixed meal, whereas in others a fast may last up to 72 hours.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
In those with a suspected [[insulinoma]], imaging is the most reliable diagnostic technique, including [[ultrasound]], [[CT scan|computed tomography]] imaging (also called CT imaging), and [[Magnetic resonance imaging|magnetic resonance imaging]] (also called MRI).
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
==Treatment==
After hypoglycemia in a person is identified, rapid treatment is necessary and can be life-saving. The main goal of treatment is to raise blood glucose back to normal levels, which is done through various ways of administering glucose, depending on the severity of the hypoglycemia, what is on-hand to treat, and who is administering the treatment. A general rule used by the [[American Diabetes Association]] is the "15-15 Rule," which suggests consuming or administering 15 grams of a [[carbohydrate]], followed by a 15-minute wait and re-measurement of blood glucose level to assess if blood glucose has returned to normal levels.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
=== Self-treatment ===
If an individual recognizes the symptoms of hypoglycemia coming on, blood sugar should promptly be measured, and a sugary food or drink should be consumed. The person must be [[Consciousness|conscious]] and able to swallow. The goal is to consume 10–20 grams of a carbohydrate to raise blood glucose levels to a minimum of 70&nbsp;mg/dL (3.9&nbsp;mmol/L).
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
Examples of products to consume are:
* Glucose tabs or gel (refer to instructions on packet)
* Juice containing sugar like apple, grape, or cranberry juice, 4 ounces or 1/2 cup 
* Soda or a soft-drink, 4 ounces or 1/2 cup (not diet soda)
* Candy
* Table sugar or honey, 1 tablespoon
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
Improvement in blood sugar levels and symptoms are expected to occur in 15–20 minutes, at which point blood sugar should be measured again. If the repeat blood sugar level is not above 70&nbsp;mg/dL (3.9&nbsp;mmol/L), consume another 10–20 grams of a carbohydrate and remeasure blood sugar levels after 15–20 minutes. Repeat until blood glucose levels have returned to normal levels. The greatest improvements in blood glucose will be seen if the carbohydrate is chewed or drunk, and then swallowed. This results in the greatest ''[[bioavailability]]'' of glucose, meaning the greatest amount of glucose enters the body producing the best possible improvements in blood glucose levels. A 2019 systematic review suggests, based on very limited evidence, that [[oral administration]] of glucose leads to a bigger improvement in blood glucose levels when compared to [[buccal administration]]. This same review reported that, based on limited evidence, no difference was found in plasma glucose when administering combined oral and buccal glucose (via dextrose gel) compared to only oral administration. The second best way to consume a carbohydrate it to allow it to dissolve under the tongue, also referred to as ''[[sublingual administration]].'' For example, a hard candy can be dissolved under the tongue, however the best improvements in blood glucose will occur if the hard candy is chewed and crushed, then swallowed.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
After correcting blood glucose levels, people may consume a full meal within one hour to replenish glycogen stores.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
==== Education ====
Family, friends, and co-workers of a person with diabetes may provide life-saving treatment in the case of a hypoglycemic episode It is important for these people to receive training on how to recognize hypoglycemia, what foods to help the hypoglycemic eat, how to administer injectable or intra-nasal [[glucagon]], and how to use a [[glucose meter]].
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
[[File:GlucaGen.jpg|thumb|A glucagon kit used to treat severe hypoglycemia.|421x421px]]
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
=== Treatment by family, friends, or co-workers ===
Family, friends, and co-workers of those with hypoglycemia are often first to identify hypoglycemic episodes, and may offer help. Upon recognizing the signs and symptoms of hypoglycemia in a diabetic, a blood sugar level should first be measured using a [[glucose meter]]. If blood glucose is below 70&nbsp;mg/dL (3.9&nbsp;mmol/L), treatment will depend on whether the person is conscious and can swallow safely. If the person is conscious and able to swallow, the family, friend, or co-worker can help the hypoglycemic consume 10–20 grams of a [[carbohydrate]] to raise blood glucose levels to a minimum of 70&nbsp;mg/dL (3.9&nbsp;mmol/L). Improvement in blood sugar level and symptoms is expected to occur in 15–20 minutes, at which point blood sugar is measured again. If the repeat blood sugar level is not above 70&nbsp;mg/dL (3.9&nbsp;mmol/L), the hypoglycemic should consume another 10–20 grams of a carbohydrate and with remeasurement of blood sugar levels after 15–20 minutes. Repeat until blood glucose levels have returned to normal levels, or call emergency services for further assistance.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
If the person is unconscious, a [[Glucagon (medication)|glucagon]] kit may be used to treat severe hypoglycemia, which delivers glucagon either by injection into a muscle or through nasal inhalation. In the United States, glucacon kits are available by prescription for diabetic patients to carry in case of an episode of severe hypoglycemia. Emergency services should be called for further assistance.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
=== Treatment by medical professionals ===
In a healthcare setting, treatment depends on the severity of symptoms and [[Intravenous therapy|intravenous]] access. If a patient is conscious and able to swallow safely, food or drink may be administered, as well as glucose tabs or gel. In those with [[Intravenous therapy|intravenous]] access, 25 grams of 50% dextrose is commonly administered. When there is no intravenous access, [[Intramuscular injection|intramuscular]] or [[Nasal administration|intra-nasal]] glucagon may be administered.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
=== Other treatments ===
While the treatment of hypoglycemia is typically managed with carbohydrate consumption, glucagon injection, or [[dextrose]] administration, there are some other treatments available. Medications like [[diazoxide]] and [[octreotide]] decrease insulin levels, increasing blood glucose levels. [[Dasiglucagon]] was approved for medical use in the United States in March 2021, to treat severe hypoglycemia. [[Dasiglucagon]] (brand name Zegalogue) is unique because it is glucagon in a prefilled syringe or auto-injector pen, as opposed to traditional glucagon kits that require mixing powdered glucagon with a liquid.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
The soft drink [[Lucozade]] has been used for hypoglycemia in the United Kingdom, but it has recently replaced much of its glucose with artificial sweeteners, which do not treat hypoglycemia.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
==Prevention==
[[File:Insulin pump with infusion set.jpg|thumb|258x258px|An insulin pump used to deliver appropriate levels of insulin.]]
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
=== Diabetics ===
The prevention of hypoglycemia depends on the cause. In those with diabetes treated by [[Insulin (medication)|insulin]], [[Meglitinide|glinides]], or [[sulfonylurea]], the prevention of hypoglycemia has a large focus on patient education and medication adjustments. The foundation of diabetes education is learning how to recognize the signs and symptoms of hypoglycemia, as well as learning how to act quickly to prevent worsening of an episode. Another cornerstone of prevention is strong self-monitoring of blood glucose, with consistent and frequent measurements. Research has shown that patients with type 1 diabetes who use [[continuous glucose monitor]]ing systems with [[insulin pump]]s significantly improve blood glucose control. Insulin pumps help to prevent high glucose spikes, and help prevent inappropriate insulin dosing. [[Continuous glucose monitor]]s can sound alarms when blood glucose is too low or too high, especially helping those with nocturnal hypoglycemia or hypoglycemic unawareness. In terms of medication adjustments, medication doses and timing can be adjusted to prevent hypoglycemia, or a medication can be stopped altogether.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
=== Non-diabetics ===
In those with hypoglycemia who do not have diabetes, there are a number of preventative measures dependent on the cause. Hypoglycemia caused by hormonal dysfunction like lack of [[cortisol]] in [[Addison's disease]] or lack of [[growth hormone]] in [[hypopituitarism]] can be prevented with appropriate hormone replacement. The hypoglycemic episodes associated with non-B cell tumors can be decreased following surgical removal of the tumor, as well as following [[Radiation therapy|radiotherapy]] or [[chemotherapy]] to reduce the size of the [[Neoplasm|tumor]]. In some cases, those with non-B cell tumors may have [[hormone therapy]] with [[growth hormone]], [[glucocorticoid]], or [[octreotide]] to also lessen hypoglycemic episodes. Post-gastric bypass hypoglycemia can be prevented by eating smaller, more frequent meals, avoiding sugar-filled foods, as well as medical treatment with an [[alpha-glucosidase inhibitor]], [[diazoxide]], or [[octreotide]].
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
Some causes of hypoglycemia require treatment of the underlying cause to best prevent hypoglycemia. This is the case for [[insulinoma]]s which often require surgical removal of the tumor for hypoglycemia to remit. In patients who cannot undergo surgery for removal of the insulinoma, [[diazoxide]] or [[octreotide]] may be used.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
== Epidemiology ==
Hypoglycemia is common in people with [[type 1 diabetes]], and in people with [[type 2 diabetes]] taking [[Insulin (medication)|insulin]], [[Meglitinide|glinides]], or [[sulfonylurea]]. It is estimated that type 1 diabetics experience two mild, symptomatic episodes of hypoglycemia ''per week.'' Additionally, people with type 1 diabetes have at least one severe hypoglyemic episode ''per year'', requiring treatment assistance. In terms of [[Mortality rate|mortality]], hypoglycemia causes death in 6–10% of type 1 diabetics.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
In those with [[type 2 diabetes]], hypoglycemia is less common compared to [[Type 1 diabetes|type 1 diabetics]], because medications that treat type 2 diabetes like [[metformin]], [[Thiazolidinedione|glitazones]], [[alpha-glucosidase inhibitor]]s, [[Glucagon-like peptide-1 receptor agonist|glucagon-like peptide 1 agonists]], and [[Dipeptidyl-peptidase IV family|dipeptidyl peptidase IV]] inhibitors, do not cause hypoglycemia. Hypoglycemia is common in type 2 diabetics who take [[Insulin (medication)|insulin]], [[Meglitinide|glinides]], or [[sulfonylurea]]. Insulin use remains a key risk factor in developing hypoglycemia, regardless of diabetes type.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
==History==
Hypoglycemia was first discovered by [[James Collip]] when he was working with [[Frederick Banting]] on purifying insulin in 1922. Collip was asked to develop an assay to measure the activity of insulin. He first injected insulin into a rabbit, and then measured the reduction in blood-glucose levels. Measuring blood glucose was a time-consuming step. Collip observed that if he injected rabbits with a too large a dose of insulin, the rabbits began convulsing, went into a coma, and then died. This observation simplified his assay. He defined one unit of insulin as the amount necessary to induce this convulsing hypoglycemic reaction in a rabbit. Collip later found he could save money, and rabbits, by injecting them with glucose once they were convulsing.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
==Etymology==
The word ''hypoglycemia'' is [[American and British English spelling differences#ae and oe|also spelled]] ''hypoglycaemia'' or ''hypoglycæmia''. The term means 'low blood sugar' from [[Greek language|Greek]] ὑπογλυκαιμία, from ὑπο- ''hypo-'' 'under' + γλυκύς ''glykys'' 'sweet' + αἷμᾰ ''haima'' 'blood'.
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
== External links ==
* [http://www.mayoclinic.com/health/hypoglycemia/ds00198/ Hypoglycemia at the Mayo Clinic]
* [https://www.diabetes.org/healthy-living/medication-treatments/blood-glucose-testing-and-control/hypoglycemia American Diabetes Association]
* {{cite web | url = https://medlineplus.gov/hypoglycemia.html | publisher = U.S. National Library of Medicine | work = MedlinePlus | title = Hypoglycemia }}
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
{{Medical resources
 | DiseasesDB     = 6431
 | ICD11          = {{ICD11|5A21}}, {{ICD11|KB60.4}}, {{ICD11|5A45}}, {{ICD11|8D8D}}, {{ICD11|5A41}}
 | ICD10          = {{ICD10|E16.0}}–{{ICD10|E16.2}}
 | ICD9           = {{ICD9|250.8}}, {{ICD9|251.0}}, {{ICD9|251.1}}, {{ICD9|251.2}}, {{ICD9|270.3}}, {{ICD9|775.6}}, {{ICD9|962.3}}
 | ICDO           =
 | OMIM           =
 | MedlinePlus    = 000386
 | eMedicineSubj  = emerg
 | eMedicineTopic = 272
 | eMedicine_mult = {{eMedicine2|med|1123}} {{eMedicine2|med|1939}} {{eMedicine2|ped|1117}}
 | MeshID         = D007003
}}
{{Disease of the pancreas and glucose metabolism|state=expanded}}
{{Blood tests}}
</div>

<div lang="en" dir="ltr" class="mw-content-ltr">
{{二次利用|date=6 February 2024}}
[[Category:Disorders of endocrine pancreas]]
[[Category:Medical emergencies]]
[[Category:Wikipedia medicine articles ready to translate]]
[[Category:Disorders causing seizures]]
[[Category:Wikipedia emergency medicine articles ready to translate]]
</div>

Export translations

Navigation menu

Search